HIV vaccine: better to start together?

Lancet HIV. 2019 Nov;6(11):e724-e725. doi: 10.1016/S2352-3018(19)30323-6. Epub 2019 Oct 7.

Authors

Barbara K Felber¹, George N Pavlakis²

Affiliations

¹ Human Retrovirus Pathogenesis Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute, Frederick, MD 21702, USA. Electronic address: Barbara.felber@nih.gov.
² Human Retrovirus Section, Vaccine Branch, Center for Cancer Research, National Cancer Institute, Frederick, MD 21702, USA.

PMID: 31601543
DOI: 10.1016/S2352-3018(19)30323-6

No abstract available

Publication types

Comment

MeSH terms

AIDS Vaccines*
DNA
Double-Blind Method
HIV Infections*
HIV-1 / immunology*
Humans

Substances

AIDS Vaccines
DNA